2023-03-202024-03-312024-03-31false14742401VekMed Limited2024-07-05iso4217:GBPxbrli:pure147424012023-03-20147424012024-03-31147424012023-03-202024-03-31147424012023-03-19147424012023-03-19147424012023-03-192023-03-1914742401bus:SmallEntities2023-03-202024-03-3114742401bus:AuditExempt-NoAccountantsReport2023-03-202024-03-3114742401bus:AbridgedAccounts2023-03-202024-03-3114742401bus:PrivateLimitedCompanyLtd2023-03-202024-03-3114742401core:WithinOneYear2024-03-3114742401core:AfterOneYear2024-03-3114742401core:WithinOneYear2023-03-1914742401core:AfterOneYear2023-03-1914742401core:ShareCapital2024-03-3114742401core:SharePremium2024-03-3114742401core:RevaluationReserve2024-03-3114742401core:OtherReservesSubtotal2024-03-3114742401core:RetainedEarningsAccumulatedLosses2024-03-3114742401core:ShareCapital2023-03-1914742401core:SharePremium2023-03-1914742401core:RevaluationReserve2023-03-1914742401core:OtherReservesSubtotal2023-03-1914742401core:RetainedEarningsAccumulatedLosses2023-03-1914742401core:LandBuildings2024-03-3114742401core:PlantMachinery2024-03-3114742401core:Vehicles2024-03-3114742401core:FurnitureFittings2024-03-3114742401core:OfficeEquipment2024-03-3114742401core:NetGoodwill2024-03-3114742401core:IntangibleAssetsOtherThanGoodwill2024-03-3114742401core:ListedExchangeTraded2024-03-3114742401core:UnlistedNon-exchangeTraded2024-03-3114742401core:LandBuildings2023-03-1914742401core:PlantMachinery2023-03-1914742401core:Vehicles2023-03-1914742401core:FurnitureFittings2023-03-1914742401core:OfficeEquipment2023-03-1914742401core:NetGoodwill2023-03-1914742401core:IntangibleAssetsOtherThanGoodwill2023-03-1914742401core:ListedExchangeTraded2023-03-1914742401core:UnlistedNon-exchangeTraded2023-03-1914742401core:LandBuildings2023-03-202024-03-3114742401core:PlantMachinery2023-03-202024-03-3114742401core:Vehicles2023-03-202024-03-3114742401core:FurnitureFittings2023-03-202024-03-3114742401core:OfficeEquipment2023-03-202024-03-3114742401core:NetGoodwill2023-03-202024-03-3114742401core:IntangibleAssetsOtherThanGoodwill2023-03-202024-03-3114742401core:ListedExchangeTraded2023-03-202024-03-3114742401core:UnlistedNon-exchangeTraded2023-03-202024-03-3114742401core:MoreThanFiveYears2023-03-202024-03-3114742401core:Non-currentFinancialInstruments2024-03-3114742401core:Non-currentFinancialInstruments2023-03-1914742401dpl:CostSales2023-03-202024-03-3114742401dpl:DistributionCosts2023-03-202024-03-3114742401core:LandBuildings2023-03-202024-03-3114742401core:PlantMachinery2023-03-202024-03-3114742401core:Vehicles2023-03-202024-03-3114742401core:FurnitureFittings2023-03-202024-03-3114742401core:OfficeEquipment2023-03-202024-03-3114742401dpl:AdministrativeExpenses2023-03-202024-03-3114742401core:NetGoodwill2023-03-202024-03-3114742401core:IntangibleAssetsOtherThanGoodwill2023-03-202024-03-3114742401dpl:GroupUndertakings2023-03-202024-03-3114742401dpl:ParticipatingInterests2023-03-202024-03-3114742401dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-202024-03-3114742401core:ListedExchangeTraded2023-03-202024-03-3114742401dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-202024-03-3114742401core:UnlistedNon-exchangeTraded2023-03-202024-03-3114742401dpl:CostSales2023-03-192023-03-1914742401dpl:DistributionCosts2023-03-192023-03-1914742401core:LandBuildings2023-03-192023-03-1914742401core:PlantMachinery2023-03-192023-03-1914742401core:Vehicles2023-03-192023-03-1914742401core:FurnitureFittings2023-03-192023-03-1914742401core:OfficeEquipment2023-03-192023-03-1914742401dpl:AdministrativeExpenses2023-03-192023-03-1914742401core:NetGoodwill2023-03-192023-03-1914742401core:IntangibleAssetsOtherThanGoodwill2023-03-192023-03-1914742401dpl:GroupUndertakings2023-03-192023-03-1914742401dpl:ParticipatingInterests2023-03-192023-03-1914742401dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-192023-03-1914742401core:ListedExchangeTraded2023-03-192023-03-1914742401dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-192023-03-1914742401core:UnlistedNon-exchangeTraded2023-03-192023-03-1914742401core:NetGoodwill2024-03-3114742401core:IntangibleAssetsOtherThanGoodwill2024-03-3114742401core:LandBuildings2024-03-3114742401core:PlantMachinery2024-03-3114742401core:Vehicles2024-03-3114742401core:FurnitureFittings2024-03-3114742401core:OfficeEquipment2024-03-3114742401core:AfterOneYear2024-03-3114742401core:WithinOneYear2024-03-3114742401core:ListedExchangeTraded2024-03-3114742401core:UnlistedNon-exchangeTraded2024-03-3114742401core:ShareCapital2024-03-3114742401core:SharePremium2024-03-3114742401core:RevaluationReserve2024-03-3114742401core:OtherReservesSubtotal2024-03-3114742401core:RetainedEarningsAccumulatedLosses2024-03-3114742401core:NetGoodwill2023-03-1914742401core:IntangibleAssetsOtherThanGoodwill2023-03-1914742401core:LandBuildings2023-03-1914742401core:PlantMachinery2023-03-1914742401core:Vehicles2023-03-1914742401core:FurnitureFittings2023-03-1914742401core:OfficeEquipment2023-03-1914742401core:AfterOneYear2023-03-1914742401core:WithinOneYear2023-03-1914742401core:ListedExchangeTraded2023-03-1914742401core:UnlistedNon-exchangeTraded2023-03-1914742401core:ShareCapital2023-03-1914742401core:SharePremium2023-03-1914742401core:RevaluationReserve2023-03-1914742401core:OtherReservesSubtotal2023-03-1914742401core:RetainedEarningsAccumulatedLosses2023-03-1914742401core:NetGoodwill2023-03-1914742401core:IntangibleAssetsOtherThanGoodwill2023-03-1914742401core:LandBuildings2023-03-1914742401core:PlantMachinery2023-03-1914742401core:Vehicles2023-03-1914742401core:FurnitureFittings2023-03-1914742401core:OfficeEquipment2023-03-1914742401core:AfterOneYear2023-03-1914742401core:WithinOneYear2023-03-1914742401core:ListedExchangeTraded2023-03-1914742401core:UnlistedNon-exchangeTraded2023-03-1914742401core:ShareCapital2023-03-1914742401core:SharePremium2023-03-1914742401core:RevaluationReserve2023-03-1914742401core:OtherReservesSubtotal2023-03-1914742401core:RetainedEarningsAccumulatedLosses2023-03-1914742401core:AfterOneYear2023-03-202024-03-3114742401core:WithinOneYear2023-03-202024-03-3114742401core:Non-currentFinancialInstrumentscore:CostValuation2023-03-202024-03-3114742401core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-202024-03-3114742401core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-202024-03-3114742401core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-202024-03-3114742401core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-202024-03-3114742401core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-202024-03-3114742401core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-202024-03-3114742401core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-202024-03-3114742401core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-202024-03-3114742401core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3114742401core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3114742401core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3114742401core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3114742401core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3114742401core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3114742401core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3114742401core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3114742401core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3114742401core:Non-currentFinancialInstrumentscore:CostValuation2023-03-1914742401core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-1914742401core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-1914742401core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-1914742401core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-1914742401core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-1914742401core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-1914742401core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-1914742401core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-1914742401bus:Director12023-03-202024-03-3114742401bus:Director22023-03-202024-03-31

VekMed Limited

Registered Number
14742401
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2024

VekMed Limited
Company Information
for the period from 20 March 2023 to 31 March 2024

Directors

Dr. Dinal Vekaria
Dipti Vekaria

Company Secretary

Dipti Vekaria

Registered Address

2 Dukes Court
Bognor Road
Chichester
PO19 8FX

Registered Number

14742401 (England and Wales)
VekMed Limited
Balance Sheet as at
31 March 2024

Notes

2024

£

£

Fixed assets
Tangible assets31,106
1,106
Current assets
Debtors5,680
Cash at bank and on hand25,193
30,873
Creditors amounts falling due within one year(10,450)
Net current assets (liabilities)20,423
Total assets less current liabilities21,529
Net assets21,529
Capital and reserves
Called up share capital2
Profit and loss account21,527
Shareholders' funds21,529
The financial statements were approved and authorised for issue by the Board of Directors on 5 July 2024, and are signed on its behalf by:
Dipti Vekaria
Director
Dr. Dinal Vekaria
Director

Registered Company No. 14742401
VekMed Limited
Notes to the Financial Statements
for the period ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Office Equipment3
2.Average number of employees

2024
Average number of employees during the year0
3.Tangible fixed assets

Total

£
Cost or valuation
Additions1,650
At 31 March 241,650
Depreciation and impairment
Charge for year544
At 31 March 24544
Net book value
At 31 March 241,106
At 19 March 23-